Medicare Enrolled

Dr. Beth Hellerstedt, M.D.

Medical Oncology · Round Rock, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2410 ROUND ROCK AVE STE 150, Round Rock, TX 78681
5123418724
In practice since 2006 (19 years)
NPI: 1215975487 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hellerstedt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hellerstedt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hellerstedt

Dr. Beth Hellerstedt is a medical oncology in Round Rock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hellerstedt performed 161,989 Medicare services across 6,928 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hellerstedt received a total of $482 from 12 pharmaceutical and/or device companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hellerstedt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in TX$ $482 industry payments

Medicare Practice Summary

Medicare Utilization ↗
161,989
Medicare services
Top 3% in TX for medical oncology
6,928
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,526 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)41,200$0$2
Pembrolizumab injection (Keytruda)25,800$43$137
Filgrastim injection (Zarxio) for white blood cells18,240$0$2
Contrast dye for imaging (iodine-based)16,101$0$3
Anti-nausea injection (fosaprepitant)11,250$0$5
Anti-nausea injection (aprepitant)9,750$1$8
Injection, docetaxel, 1 mg5,459$0$66
Denosumab injection (Prolia/Xgeva)4,860$18$66
Dexamethasone injection (steroid)3,506$0$1
Injection, granisetron hydrochloride, 100 mcg2,100$0$24
Complete blood count (CBC) with differential2,036$8$36
Comprehensive metabolic blood panel1,963$10$64
Blood draw (venipuncture)1,897$8$20
Lactate dehydrogenase (enzyme) level1,889$6$31
Anti-nausea injection (Aloxi/palonosetron)1,820$1$114
Injection of additional new drug or substance into vein1,108$12$108
Injection, magnesium sulfate, per 500 mg1,000$1$6
Flow cytometry, additional marker792$20$180
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg768$92$1,348
Administration of chemotherapy into vein, 1 hour or less711$97$707
Office visit, established patient (20-29 min)694$56$250
Magnesium level test561$7$29
Immunoglobulin level test513$9$56
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less422$47$313
Office visit, established patient, complex (40-54 min)421$130$496
Injection, zoledronic acid, 1 mg419$7$431
Drug injection, under skin or into muscle385$10$96
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less382$22$157
Office visit, established patient (30-39 min)356$92$368
Ferritin level test (iron stores)326$13$60
Measurement of immunoglobulin light chains320$17$60
Iron level test310$6$27
Iron binding capacity test310$9$35
Leuprolide acetate (for depot suspension), 7.5 mg304$132$3,675
Infusion, normal saline solution , 1000 cc244$2$19
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle219$24$145
Injection, diphenhydramine hcl, up to 50 mg208$1$7
Piflufolastat f-18, diagnostic, 1 millicurie179$579$1,749
Administration of additional new drug or substance into vein, 1 hour or less158$49$344
Administration of chemotherapy into vein, each additional hour157$21$161
Beta-2 microglobulin (protein) level153$16$96
Nuclear medicine study from skull base to mid-thigh with ct scan152$1,133$4,802
Infusion into a vein for hydration, 31-60 minutes148$24$256
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries143$90$657
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services143$70$70
Microscopic examination for white blood cells with manual cell count133$4$22
Complete blood count (CBC), automated133$6$34
Reticulated (young) platelet measurement127$34$143
Ct scan of chest with contrast123$47$821
Unclassified drugs122$1$8
Vitamin D level test121$29$250
Injection, methylprednisolone sodium succinate, up to 40 mg110$3$14
Protein measurement, serum101$11$99
Infusion into a vein for hydration, each additional hour100$9$75
Immunologic analysis technique on serum99$29$108
Immunologic analysis technique on serum (immunofixation)98$22$160
PSA test (prostate cancer screening)97$18$94
CT scan of abdomen and pelvis with contrast96$163$1,067
Testosterone (hormone) level, total88$25$143
Infusion, normal saline solution, sterile (500 ml = 1 unit)79$1$19
Application of on-body injector for under skin injection62$14$96
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session57$272$2,762
New patient office visit, complex (60-74 min)48$157$709
Irrigation of implanted venous access drug delivery device35$19$114
Flow cytometry technique for dna or cell analysis, first marker33$56$298
Echocardiogram, transthoracic30$121$813
CT scan of chest, without contrast27$46$686
Red blood count automated, with additional calculations24$5$26
New patient office visit (30-44 min)24$71$372
Ct scan of soft tissue of neck with contrast22$74$658
Urinalysis with microscopic exam21$3$28
Uric acid level test20$4$25
Hospital follow-up visit, high complexity20$89$357
Nuclear medicine study whole body with ct scan18$1,136$4,929
Red blood count, automated test18$4$23
Ct scan of abdomen and pelvis without contrast15$70$560
New patient office visit (45-59 min)11$127$565
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
89.9% medium
9.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$482
Total received (2018-2024)
Avg $80/year across 6 years
Bottom 22% in TX for medical oncology
12
Companies
23
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$257 (53.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$225 (46.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$93
2023
$49
2022
$192
2021
$24
2020
$32
2018
$92

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$138
Sunovion Pharmaceuticals Inc.
$92
Foundation Medicine, Inc.
$56
Novartis Pharmaceuticals Corporation
$44
Apellis Pharmaceuticals, Inc.
$30
AVEO Pharmaceuticals, Inc.
$27
Janssen Pharmaceuticals, Inc
$22
E.R. Squibb & Sons, L.L.C.
$17
Regeneron Healthcare Solutions, Inc.
$17
Tactile Systems Technology Inc
$15
Acrotech Biopharma LLC
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 59.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · BELEODAQ · DARZALEX · ERLEADA · Empaveli · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · LIBTAYO · LONHALA MAGNAIR · OPDIVO · RYBREVANT · TECVAYLI · Utibron
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $0 per 100 Medicare services performed
Looking for a medical oncology in Round Rock?
Compare medical oncologys in the Round Rock area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
27
Per 100K population
4.2
County median income
$108,309
Nearest hospital
ROUND ROCK MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hellerstedt is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hellerstedt experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Hellerstedt performed 41,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hellerstedt receive payments from pharmaceutical companies?
Yes. Dr. Hellerstedt received a total of $482 from 12 companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hellerstedt's costs compare to other medical oncologys in Round Rock?
Dr. Hellerstedt's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hellerstedt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →